Testing effectiveness (Phase 2)Looking for participantsNCT07469683
What this trial is testing
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Who this might be right for
Clear Cell Renal Cell CarcinomaNeoplasmsMalignant Neoplasms+1 more
Yonsei University 78